Trial
NCT01587235
A Study to Evaluate the Efficacy and Safety of Vytorin Versus Standard Treatment of Other Statins in Moderate, Moderately High and High Risk Participants (MK-0653A-406)
Phase IVWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Organon and Co
Collaborators
—
Condition
Dyslipidemia
Intervention
Ezetimibe/simvastatin
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-02-18